PULSE BIOSCIENCES, INC.
A bioelectric medicine company developing non-thermal nsPFA technology for tissue ablation.
PLSE | US
Overview
Corporate Details
- ISIN(s):
- US74587B1017
- LEI:
- Country:
- United States of America
- Address:
- 3957 POINT EDEN WAY, 94545 HAYWARD
Description
Pulse Biosciences, Inc. is a bioelectric medicine company developing its proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology. This non-thermal energy platform delivers nanosecond-duration electrical pulses to ablate cellular tissue while sparing adjacent noncellular structures. The company's primary focus is on advancing treatments in cardiology, particularly for atrial fibrillation, through investigational devices such as the CellFX® nsPFA™ 360 Cardiac Catheter and a surgical cardiac clamp. Pulse Biosciences is also developing its technology for non-cardiac applications, including the use of percutaneous electrodes for treating conditions like benign thyroid nodules. The nsPFA technology aims to provide a potentially safer and more efficient alternative to conventional thermal ablation methods across a broad spectrum of medical procedures.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PULSE BIOSCIENCES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PULSE BIOSCIENCES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PULSE BIOSCIENCES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
